Rocket Pharmaceuticals Inc (RCKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 231,747 | 273,205 | 259,659 | 224,343 | 167,248 |
| Operating Income | -231,747 | -273,205 | -259,659 | -224,343 | -167,248 |
| Interest Expense | 1,891 | 1,886 | 1,875 | 1,862 | 2,977 |
| Other Income | 10,515 | 16,345 | 15,939 | 4,342 | 1,156 |
| Pre-tax Income | -223,123 | -258,746 | -245,595 | -221,863 | -169,069 |
| Net Income Continuous | -223,123 | -258,746 | -245,595 | -221,863 | -169,069 |
| Net Income | $-223,123 | $-258,746 | $-245,595 | $-221,863 | $-169,069 |
| EPS Basic Total Ops | -2.01 | -2.73 | -2.92 | -3.26 | -2.67 |
| EPS Basic Continuous Ops | -2.01 | -2.73 | -2.92 | -3.26 | -2.67 |
| EPS Diluted Total Ops | -2.01 | -2.73 | -2.92 | -3.26 | -2.67 |
| EPS Diluted Continuous Ops | -2.01 | -2.73 | -2.92 | -3.26 | -2.67 |
| EPS Diluted Before Non-Recurring Items | N/A | -2.73 | -2.92 | -3.26 | -2.67 |
| EBITDA(a) | $-220,460 | $-263,830 | $-252,561 | $-218,077 | $-161,875 |